hyperCORE International Appoints Nicholas Focil as New President
July 29th, 2025 7:00 AM
By: Newsworthy Staff
Nicholas Focil's appointment as president of hyperCORE International marks a significant step towards enhancing the network's global clinical research impact, leveraging his extensive experience in clinical operations and strategic partnerships.
hyperCORE International has announced Nicholas Focil as its new president, bringing nearly two decades of clinical operations leadership and strategic partnership expertise to the role. Focil, founder and CEO of FOMAT Medical Research, is recognized for his work in expanding clinical trials into emerging markets and promoting trial diversity. His leadership is expected to further hyperCORE's mission of conducting ethical, high-quality clinical research across its network of over 80 trial sites.
Outgoing president Carlos Orantes praised Focil's appointment as a milestone for hyperCORE, highlighting the network's continued path of excellence under new leadership. Focil expressed gratitude for Orantes's contributions and outlined his vision for enhancing site capabilities and broadening the reach of clinical trials to benefit patients and sponsors alike.
Source Statement
This news article relied primarily on a press release disributed by 24-7 Press Release. You can read the source press release here,
